nodes	percent_of_prediction	percent_of_DWPC	metapath
Nitrofurantoin—POR—Nilutamide—prostate cancer	0.464	0.596	CbGbCtD
Nitrofurantoin—POR—Doxorubicin—prostate cancer	0.0712	0.0914	CbGbCtD
Nitrofurantoin—ABCG2—Cabazitaxel—prostate cancer	0.0517	0.0663	CbGbCtD
Nitrofurantoin—ABCG2—Estrone—prostate cancer	0.0505	0.0648	CbGbCtD
Nitrofurantoin—ABCG2—Conjugated Estrogens—prostate cancer	0.033	0.0424	CbGbCtD
Nitrofurantoin—ABCG2—Mitoxantrone—prostate cancer	0.03	0.0385	CbGbCtD
Nitrofurantoin—ABCG2—Estradiol—prostate cancer	0.029	0.0372	CbGbCtD
Nitrofurantoin—ABCG2—Etoposide—prostate cancer	0.0189	0.0243	CbGbCtD
Nitrofurantoin—ABCG2—Docetaxel—prostate cancer	0.0173	0.0222	CbGbCtD
Nitrofurantoin—ABCG2—Doxorubicin—prostate cancer	0.0129	0.0166	CbGbCtD
Nitrofurantoin—POR—Oxidation by Cytochrome P450—CYP3A43—prostate cancer	0.00335	0.087	CbGpPWpGaD
Nitrofurantoin—POR—Oxidation by Cytochrome P450—CYP7B1—prostate cancer	0.0026	0.0676	CbGpPWpGaD
Nitrofurantoin—ABCG2—Abacavir transmembrane transport—SLC22A3—prostate cancer	0.00258	0.0671	CbGpPWpGaD
Nitrofurantoin—POR—prostate gland—prostate cancer	0.0025	0.18	CbGeAlD
Nitrofurantoin—POR—Oxidation by Cytochrome P450—CYP3A5—prostate cancer	0.00223	0.058	CbGpPWpGaD
Nitrofurantoin—POR—seminal vesicle—prostate cancer	0.00211	0.152	CbGeAlD
Nitrofurantoin—ABCG2—Abacavir transmembrane transport—SLC22A1—prostate cancer	0.0021	0.0547	CbGpPWpGaD
Nitrofurantoin—POR—Oxidation by Cytochrome P450—CYP2C18—prostate cancer	0.00176	0.0457	CbGpPWpGaD
Nitrofurantoin—POR—urethra—prostate cancer	0.00167	0.121	CbGeAlD
Nitrofurantoin—ABCG2—Abacavir transport and metabolism—SLC22A3—prostate cancer	0.00148	0.0385	CbGpPWpGaD
Nitrofurantoin—POR—Oxidation by Cytochrome P450—CYP2C19—prostate cancer	0.00146	0.0379	CbGpPWpGaD
Nitrofurantoin—POR—Oxidation by Cytochrome P450—CYP2A6—prostate cancer	0.00141	0.0365	CbGpPWpGaD
Nitrofurantoin—POR—Oxidation by Cytochrome P450—CYP17A1—prostate cancer	0.00135	0.035	CbGpPWpGaD
Nitrofurantoin—POR—bone marrow—prostate cancer	0.00129	0.0928	CbGeAlD
Nitrofurantoin—ABCG2—Irinotecan Pathway—CYP3A5—prostate cancer	0.00123	0.0319	CbGpPWpGaD
Nitrofurantoin—ABCG2—Abacavir transport and metabolism—SLC22A1—prostate cancer	0.00121	0.0314	CbGpPWpGaD
Nitrofurantoin—POR—Oxidation by Cytochrome P450—CYP2E1—prostate cancer	0.0012	0.0311	CbGpPWpGaD
Nitrofurantoin—ABCG2—prostate gland—prostate cancer	0.00116	0.0837	CbGeAlD
Nitrofurantoin—POR—Oxidation by Cytochrome P450—CYP3A4—prostate cancer	0.00115	0.03	CbGpPWpGaD
Nitrofurantoin—POR—Oxidation by Cytochrome P450—CYP1B1—prostate cancer	0.00113	0.0294	CbGpPWpGaD
Nitrofurantoin—POR—testis—prostate cancer	0.0011	0.0794	CbGeAlD
Nitrofurantoin—POR—Oxidation by Cytochrome P450—CYP19A1—prostate cancer	0.00107	0.0277	CbGpPWpGaD
Nitrofurantoin—ABCG2—seminal vesicle—prostate cancer	0.000982	0.0708	CbGeAlD
Nitrofurantoin—POR—Oxidation by Cytochrome P450—CYP1A1—prostate cancer	0.000859	0.0223	CbGpPWpGaD
Nitrofurantoin—POR—lymph node—prostate cancer	0.000798	0.0575	CbGeAlD
Nitrofurantoin—ABCG2—urethra—prostate cancer	0.000777	0.056	CbGeAlD
Nitrofurantoin—ABCG2—Fluoropyrimidine Activity—UMPS—prostate cancer	0.000643	0.0167	CbGpPWpGaD
Nitrofurantoin—ABCG2—Irinotecan Pathway—CYP3A4—prostate cancer	0.000634	0.0165	CbGpPWpGaD
Nitrofurantoin—ABCG2—bone marrow—prostate cancer	0.000598	0.0431	CbGeAlD
Nitrofurantoin—ABCG2—testis—prostate cancer	0.000511	0.0369	CbGeAlD
Nitrofurantoin—ABCG2—HIF-1-alpha transcription factor network—BNIP3—prostate cancer	0.000508	0.0132	CbGpPWpGaD
Nitrofurantoin—ABCG2—Fluoropyrimidine Activity—CYP2A6—prostate cancer	0.00039	0.0101	CbGpPWpGaD
Nitrofurantoin—ABCG2—lymph node—prostate cancer	0.000371	0.0267	CbGeAlD
Nitrofurantoin—ABCG2—Irinotecan Pathway—APC—prostate cancer	0.00037	0.00962	CbGpPWpGaD
Nitrofurantoin—ABCG2—HIF-1-alpha transcription factor network—NDRG1—prostate cancer	0.000343	0.00892	CbGpPWpGaD
Nitrofurantoin—ABCG2—HIF-2-alpha transcription factor network—APEX1—prostate cancer	0.000299	0.00777	CbGpPWpGaD
Nitrofurantoin—ABCG2—HIF-2-alpha transcription factor network—SIRT1—prostate cancer	0.000256	0.00665	CbGpPWpGaD
Nitrofurantoin—ABCG2—Fluoropyrimidine Activity—TYMS—prostate cancer	0.000254	0.0066	CbGpPWpGaD
Nitrofurantoin—ABCG2—Imatinib Resistance in Chronic Myeloid Leukemia—GADD45A—prostate cancer	0.000251	0.00653	CbGpPWpGaD
Nitrofurantoin—ABCG2—Fluoropyrimidine Activity—ERCC2—prostate cancer	0.000236	0.00614	CbGpPWpGaD
Nitrofurantoin—ABCG2—Fluoropyrimidine Activity—MTHFR—prostate cancer	0.000222	0.00577	CbGpPWpGaD
Nitrofurantoin—ABCG2—HIF-1-alpha transcription factor network—NCOA2—prostate cancer	0.000204	0.00531	CbGpPWpGaD
Nitrofurantoin—ABCG2—HIF-2-alpha transcription factor network—KDR—prostate cancer	0.000198	0.00514	CbGpPWpGaD
Nitrofurantoin—Dantrolene—CYP3A4—prostate cancer	0.000194	1	CrCbGaD
Nitrofurantoin—ABCG2—HIF-1-alpha transcription factor network—CXCL12—prostate cancer	0.00019	0.00495	CbGpPWpGaD
Nitrofurantoin—ABCG2—Imatinib Resistance in Chronic Myeloid Leukemia—PDGFRB—prostate cancer	0.000178	0.00463	CbGpPWpGaD
Nitrofurantoin—ABCG2—HIF-1-alpha transcription factor network—NCOA1—prostate cancer	0.000172	0.00447	CbGpPWpGaD
Nitrofurantoin—ABCG2—HIF-2-alpha transcription factor network—CREBBP—prostate cancer	0.000169	0.00439	CbGpPWpGaD
Nitrofurantoin—ABCG2—HIF-2-alpha transcription factor network—SERPINE1—prostate cancer	0.000158	0.00411	CbGpPWpGaD
Nitrofurantoin—ABCG2—HIF-1-alpha transcription factor network—TERT—prostate cancer	0.000127	0.0033	CbGpPWpGaD
Nitrofurantoin—ABCG2—HIF-1-alpha transcription factor network—HIF1A—prostate cancer	0.000122	0.00316	CbGpPWpGaD
Nitrofurantoin—ABCG2—HIF-1-alpha transcription factor network—LEP—prostate cancer	0.000119	0.00308	CbGpPWpGaD
Nitrofurantoin—ABCG2—HIF-2-alpha transcription factor network—EP300—prostate cancer	0.000115	0.00299	CbGpPWpGaD
Nitrofurantoin—Dyspnoea—Mitoxantrone—prostate cancer	0.000113	0.000672	CcSEcCtD
Nitrofurantoin—Erythema multiforme—Capecitabine—prostate cancer	0.000113	0.000671	CcSEcCtD
Nitrofurantoin—Cough—Etoposide—prostate cancer	0.000113	0.00067	CcSEcCtD
Nitrofurantoin—Somnolence—Mitoxantrone—prostate cancer	0.000113	0.00067	CcSEcCtD
Nitrofurantoin—Dizziness—Conjugated Estrogens—prostate cancer	0.000113	0.000668	CcSEcCtD
Nitrofurantoin—Feeling abnormal—Estradiol—prostate cancer	0.000112	0.000666	CcSEcCtD
Nitrofurantoin—Dyspepsia—Mitoxantrone—prostate cancer	0.000112	0.000663	CcSEcCtD
Nitrofurantoin—Gastrointestinal pain—Estradiol—prostate cancer	0.000111	0.000661	CcSEcCtD
Nitrofurantoin—Chills—Docetaxel—prostate cancer	0.000111	0.000658	CcSEcCtD
Nitrofurantoin—Decreased appetite—Mitoxantrone—prostate cancer	0.00011	0.000655	CcSEcCtD
Nitrofurantoin—Chest pain—Etoposide—prostate cancer	0.00011	0.000654	CcSEcCtD
Nitrofurantoin—Vomiting—Goserelin—prostate cancer	0.000109	0.000648	CcSEcCtD
Nitrofurantoin—Alopecia—Docetaxel—prostate cancer	0.000109	0.000648	CcSEcCtD
Nitrofurantoin—ABCG2—Transmembrane transport of small molecules—SLC7A1—prostate cancer	0.000109	0.00284	CbGpPWpGaD
Nitrofurantoin—ABCG2—HIF-2-alpha transcription factor network—VEGFA—prostate cancer	0.000109	0.00283	CbGpPWpGaD
Nitrofurantoin—Discomfort—Etoposide—prostate cancer	0.000109	0.000646	CcSEcCtD
Nitrofurantoin—Constipation—Mitoxantrone—prostate cancer	0.000109	0.000644	CcSEcCtD
Nitrofurantoin—Aspartate aminotransferase increased—Epirubicin—prostate cancer	0.000108	0.000644	CcSEcCtD
Nitrofurantoin—Rash—Goserelin—prostate cancer	0.000108	0.000643	CcSEcCtD
Nitrofurantoin—Vomiting—Conjugated Estrogens—prostate cancer	0.000108	0.000642	CcSEcCtD
Nitrofurantoin—Body temperature increased—Estradiol—prostate cancer	0.000108	0.000639	CcSEcCtD
Nitrofurantoin—Abdominal pain—Estradiol—prostate cancer	0.000108	0.000639	CcSEcCtD
Nitrofurantoin—Headache—Goserelin—prostate cancer	0.000108	0.000639	CcSEcCtD
Nitrofurantoin—Rash—Conjugated Estrogens—prostate cancer	0.000107	0.000637	CcSEcCtD
Nitrofurantoin—Chills—Capecitabine—prostate cancer	0.000107	0.000637	CcSEcCtD
Nitrofurantoin—Headache—Conjugated Estrogens—prostate cancer	0.000107	0.000633	CcSEcCtD
Nitrofurantoin—Confusional state—Etoposide—prostate cancer	0.000106	0.000632	CcSEcCtD
Nitrofurantoin—Alanine aminotransferase increased—Epirubicin—prostate cancer	0.000106	0.00063	CcSEcCtD
Nitrofurantoin—Alopecia—Capecitabine—prostate cancer	0.000106	0.000627	CcSEcCtD
Nitrofurantoin—Anaphylactic shock—Etoposide—prostate cancer	0.000106	0.000627	CcSEcCtD
Nitrofurantoin—Feeling abnormal—Mitoxantrone—prostate cancer	0.000105	0.000621	CcSEcCtD
Nitrofurantoin—Asthma—Epirubicin—prostate cancer	0.000104	0.000618	CcSEcCtD
Nitrofurantoin—Gastrointestinal pain—Mitoxantrone—prostate cancer	0.000104	0.000616	CcSEcCtD
Nitrofurantoin—Thrombocytopenia—Etoposide—prostate cancer	0.000103	0.000613	CcSEcCtD
Nitrofurantoin—Eosinophilia—Epirubicin—prostate cancer	0.000103	0.000612	CcSEcCtD
Nitrofurantoin—Flatulence—Capecitabine—prostate cancer	0.000103	0.000609	CcSEcCtD
Nitrofurantoin—Nausea—Goserelin—prostate cancer	0.000102	0.000606	CcSEcCtD
Nitrofurantoin—Nausea—Conjugated Estrogens—prostate cancer	0.000101	0.0006	CcSEcCtD
Nitrofurantoin—Anorexia—Etoposide—prostate cancer	0.000101	0.000597	CcSEcCtD
Nitrofurantoin—Hypersensitivity—Estradiol—prostate cancer	0.0001	0.000596	CcSEcCtD
Nitrofurantoin—Body temperature increased—Mitoxantrone—prostate cancer	0.0001	0.000595	CcSEcCtD
Nitrofurantoin—Abdominal pain—Mitoxantrone—prostate cancer	0.0001	0.000595	CcSEcCtD
Nitrofurantoin—Aspartate aminotransferase increased—Doxorubicin—prostate cancer	0.0001	0.000595	CcSEcCtD
Nitrofurantoin—Anaemia—Docetaxel—prostate cancer	9.94e-05	0.00059	CcSEcCtD
Nitrofurantoin—ABCG2—HIF-1-alpha transcription factor network—CREBBP—prostate cancer	9.93e-05	0.00258	CbGpPWpGaD
Nitrofurantoin—Alanine aminotransferase increased—Doxorubicin—prostate cancer	9.83e-05	0.000583	CcSEcCtD
Nitrofurantoin—Asthenia—Estradiol—prostate cancer	9.78e-05	0.00058	CcSEcCtD
Nitrofurantoin—ABCG2—Imatinib Resistance in Chronic Myeloid Leukemia—CDKN1B—prostate cancer	9.77e-05	0.00254	CbGpPWpGaD
Nitrofurantoin—Ill-defined disorder—Capecitabine—prostate cancer	9.66e-05	0.000573	CcSEcCtD
Nitrofurantoin—Asthma—Doxorubicin—prostate cancer	9.63e-05	0.000571	CcSEcCtD
Nitrofurantoin—Leukopenia—Docetaxel—prostate cancer	9.63e-05	0.000571	CcSEcCtD
Nitrofurantoin—Anaemia—Capecitabine—prostate cancer	9.62e-05	0.000571	CcSEcCtD
Nitrofurantoin—Eosinophilia—Doxorubicin—prostate cancer	9.54e-05	0.000566	CcSEcCtD
Nitrofurantoin—Paraesthesia—Etoposide—prostate cancer	9.48e-05	0.000563	CcSEcCtD
Nitrofurantoin—Dyspnoea—Etoposide—prostate cancer	9.42e-05	0.000559	CcSEcCtD
Nitrofurantoin—Alopecia—Prednisone—prostate cancer	9.42e-05	0.000559	CcSEcCtD
Nitrofurantoin—Malaise—Capecitabine—prostate cancer	9.39e-05	0.000557	CcSEcCtD
Nitrofurantoin—Somnolence—Etoposide—prostate cancer	9.39e-05	0.000557	CcSEcCtD
Nitrofurantoin—Cough—Docetaxel—prostate cancer	9.39e-05	0.000557	CcSEcCtD
Nitrofurantoin—Vertigo—Capecitabine—prostate cancer	9.36e-05	0.000555	CcSEcCtD
Nitrofurantoin—Hypersensitivity—Mitoxantrone—prostate cancer	9.36e-05	0.000555	CcSEcCtD
Nitrofurantoin—Diarrhoea—Estradiol—prostate cancer	9.32e-05	0.000553	CcSEcCtD
Nitrofurantoin—Leukopenia—Capecitabine—prostate cancer	9.32e-05	0.000553	CcSEcCtD
Nitrofurantoin—ABCG2—HIF-1-alpha transcription factor network—SERPINE1—prostate cancer	9.31e-05	0.00242	CbGpPWpGaD
Nitrofurantoin—Drowsiness—Epirubicin—prostate cancer	9.28e-05	0.000551	CcSEcCtD
Nitrofurantoin—Stevens-Johnson syndrome—Epirubicin—prostate cancer	9.2e-05	0.000546	CcSEcCtD
Nitrofurantoin—Decreased appetite—Etoposide—prostate cancer	9.18e-05	0.000545	CcSEcCtD
Nitrofurantoin—Chest pain—Docetaxel—prostate cancer	9.16e-05	0.000543	CcSEcCtD
Nitrofurantoin—Myalgia—Docetaxel—prostate cancer	9.16e-05	0.000543	CcSEcCtD
Nitrofurantoin—Renal failure—Epirubicin—prostate cancer	9.13e-05	0.000541	CcSEcCtD
Nitrofurantoin—Gastrointestinal disorder—Etoposide—prostate cancer	9.12e-05	0.000541	CcSEcCtD
Nitrofurantoin—Asthenia—Mitoxantrone—prostate cancer	9.11e-05	0.00054	CcSEcCtD
Nitrofurantoin—Neuropathy peripheral—Epirubicin—prostate cancer	9.1e-05	0.00054	CcSEcCtD
Nitrofurantoin—Cough—Capecitabine—prostate cancer	9.09e-05	0.000539	CcSEcCtD
Nitrofurantoin—Constipation—Etoposide—prostate cancer	9.03e-05	0.000536	CcSEcCtD
Nitrofurantoin—Dizziness—Estradiol—prostate cancer	9.01e-05	0.000535	CcSEcCtD
Nitrofurantoin—Myalgia—Capecitabine—prostate cancer	8.87e-05	0.000526	CcSEcCtD
Nitrofurantoin—Chest pain—Capecitabine—prostate cancer	8.87e-05	0.000526	CcSEcCtD
Nitrofurantoin—Confusional state—Docetaxel—prostate cancer	8.85e-05	0.000525	CcSEcCtD
Nitrofurantoin—Anaphylactic shock—Docetaxel—prostate cancer	8.78e-05	0.000521	CcSEcCtD
Nitrofurantoin—Discomfort—Capecitabine—prostate cancer	8.76e-05	0.00052	CcSEcCtD
Nitrofurantoin—Feeling abnormal—Etoposide—prostate cancer	8.7e-05	0.000516	CcSEcCtD
Nitrofurantoin—Diarrhoea—Mitoxantrone—prostate cancer	8.69e-05	0.000515	CcSEcCtD
Nitrofurantoin—Vomiting—Estradiol—prostate cancer	8.66e-05	0.000514	CcSEcCtD
Nitrofurantoin—Agranulocytosis—Epirubicin—prostate cancer	8.66e-05	0.000514	CcSEcCtD
Nitrofurantoin—Gastrointestinal pain—Etoposide—prostate cancer	8.64e-05	0.000512	CcSEcCtD
Nitrofurantoin—ABCG2—Transmembrane transport of small molecules—SLC39A1—prostate cancer	8.63e-05	0.00224	CbGpPWpGaD
Nitrofurantoin—Ill-defined disorder—Prednisone—prostate cancer	8.61e-05	0.000511	CcSEcCtD
Nitrofurantoin—Thrombocytopenia—Docetaxel—prostate cancer	8.59e-05	0.00051	CcSEcCtD
Nitrofurantoin—Rash—Estradiol—prostate cancer	8.59e-05	0.00051	CcSEcCtD
Nitrofurantoin—Drowsiness—Doxorubicin—prostate cancer	8.59e-05	0.00051	CcSEcCtD
Nitrofurantoin—Anaemia—Prednisone—prostate cancer	8.57e-05	0.000509	CcSEcCtD
Nitrofurantoin—Confusional state—Capecitabine—prostate cancer	8.57e-05	0.000508	CcSEcCtD
Nitrofurantoin—Headache—Estradiol—prostate cancer	8.54e-05	0.000506	CcSEcCtD
Nitrofurantoin—Stevens-Johnson syndrome—Doxorubicin—prostate cancer	8.52e-05	0.000505	CcSEcCtD
Nitrofurantoin—Renal failure—Doxorubicin—prostate cancer	8.44e-05	0.000501	CcSEcCtD
Nitrofurantoin—ABCG2—Fluoropyrimidine Activity—TP53—prostate cancer	8.42e-05	0.00219	CbGpPWpGaD
Nitrofurantoin—Neuropathy peripheral—Doxorubicin—prostate cancer	8.42e-05	0.000499	CcSEcCtD
Nitrofurantoin—Anorexia—Docetaxel—prostate cancer	8.37e-05	0.000496	CcSEcCtD
Nitrofurantoin—Malaise—Prednisone—prostate cancer	8.36e-05	0.000496	CcSEcCtD
Nitrofurantoin—Abdominal pain—Etoposide—prostate cancer	8.35e-05	0.000495	CcSEcCtD
Nitrofurantoin—Body temperature increased—Etoposide—prostate cancer	8.35e-05	0.000495	CcSEcCtD
Nitrofurantoin—Vertigo—Prednisone—prostate cancer	8.33e-05	0.000494	CcSEcCtD
Nitrofurantoin—Hepatitis—Epirubicin—prostate cancer	8.33e-05	0.000494	CcSEcCtD
Nitrofurantoin—Thrombocytopenia—Capecitabine—prostate cancer	8.32e-05	0.000494	CcSEcCtD
Nitrofurantoin—Hypoaesthesia—Epirubicin—prostate cancer	8.29e-05	0.000492	CcSEcCtD
Nitrofurantoin—Anorexia—Capecitabine—prostate cancer	8.1e-05	0.000481	CcSEcCtD
Nitrofurantoin—Nausea—Estradiol—prostate cancer	8.09e-05	0.00048	CcSEcCtD
Nitrofurantoin—Vomiting—Mitoxantrone—prostate cancer	8.07e-05	0.000479	CcSEcCtD
Nitrofurantoin—Agranulocytosis—Doxorubicin—prostate cancer	8.02e-05	0.000476	CcSEcCtD
Nitrofurantoin—Rash—Mitoxantrone—prostate cancer	8.01e-05	0.000475	CcSEcCtD
Nitrofurantoin—Musculoskeletal discomfort—Docetaxel—prostate cancer	8e-05	0.000474	CcSEcCtD
Nitrofurantoin—Headache—Mitoxantrone—prostate cancer	7.95e-05	0.000472	CcSEcCtD
Nitrofurantoin—Myalgia—Prednisone—prostate cancer	7.9e-05	0.000468	CcSEcCtD
Nitrofurantoin—Paraesthesia—Docetaxel—prostate cancer	7.88e-05	0.000468	CcSEcCtD
Nitrofurantoin—Erythema multiforme—Epirubicin—prostate cancer	7.88e-05	0.000467	CcSEcCtD
Nitrofurantoin—Dyspnoea—Docetaxel—prostate cancer	7.83e-05	0.000464	CcSEcCtD
Nitrofurantoin—Somnolence—Docetaxel—prostate cancer	7.8e-05	0.000463	CcSEcCtD
Nitrofurantoin—Discomfort—Prednisone—prostate cancer	7.8e-05	0.000463	CcSEcCtD
Nitrofurantoin—Hypersensitivity—Etoposide—prostate cancer	7.78e-05	0.000462	CcSEcCtD
Nitrofurantoin—Musculoskeletal discomfort—Capecitabine—prostate cancer	7.74e-05	0.000459	CcSEcCtD
Nitrofurantoin—Dyspepsia—Docetaxel—prostate cancer	7.73e-05	0.000458	CcSEcCtD
Nitrofurantoin—Hepatitis—Doxorubicin—prostate cancer	7.71e-05	0.000457	CcSEcCtD
Nitrofurantoin—Hypoaesthesia—Doxorubicin—prostate cancer	7.67e-05	0.000455	CcSEcCtD
Nitrofurantoin—Paraesthesia—Capecitabine—prostate cancer	7.63e-05	0.000453	CcSEcCtD
Nitrofurantoin—Decreased appetite—Docetaxel—prostate cancer	7.63e-05	0.000453	CcSEcCtD
Nitrofurantoin—Gastrointestinal disorder—Docetaxel—prostate cancer	7.58e-05	0.00045	CcSEcCtD
Nitrofurantoin—Asthenia—Etoposide—prostate cancer	7.58e-05	0.00045	CcSEcCtD
Nitrofurantoin—Dyspnoea—Capecitabine—prostate cancer	7.58e-05	0.000449	CcSEcCtD
Nitrofurantoin—Anaphylactic shock—Prednisone—prostate cancer	7.57e-05	0.000449	CcSEcCtD
Nitrofurantoin—Nausea—Mitoxantrone—prostate cancer	7.54e-05	0.000447	CcSEcCtD
Nitrofurantoin—Constipation—Docetaxel—prostate cancer	7.51e-05	0.000445	CcSEcCtD
Nitrofurantoin—Dyspepsia—Capecitabine—prostate cancer	7.48e-05	0.000444	CcSEcCtD
Nitrofurantoin—Chills—Epirubicin—prostate cancer	7.48e-05	0.000444	CcSEcCtD
Nitrofurantoin—ABCG2—Imatinib Resistance in Chronic Myeloid Leukemia—MYC—prostate cancer	7.48e-05	0.00194	CbGpPWpGaD
Nitrofurantoin—Decreased appetite—Capecitabine—prostate cancer	7.39e-05	0.000438	CcSEcCtD
Nitrofurantoin—Alopecia—Epirubicin—prostate cancer	7.36e-05	0.000437	CcSEcCtD
Nitrofurantoin—Gastrointestinal disorder—Capecitabine—prostate cancer	7.34e-05	0.000435	CcSEcCtD
Nitrofurantoin—Erythema multiforme—Doxorubicin—prostate cancer	7.29e-05	0.000433	CcSEcCtD
Nitrofurantoin—Constipation—Capecitabine—prostate cancer	7.27e-05	0.000431	CcSEcCtD
Nitrofurantoin—Feeling abnormal—Docetaxel—prostate cancer	7.23e-05	0.000429	CcSEcCtD
Nitrofurantoin—Diarrhoea—Etoposide—prostate cancer	7.23e-05	0.000429	CcSEcCtD
Nitrofurantoin—Anorexia—Prednisone—prostate cancer	7.22e-05	0.000428	CcSEcCtD
Nitrofurantoin—Gastrointestinal pain—Docetaxel—prostate cancer	7.18e-05	0.000426	CcSEcCtD
Nitrofurantoin—Flatulence—Epirubicin—prostate cancer	7.15e-05	0.000424	CcSEcCtD
Nitrofurantoin—ABCG2—Transmembrane transport of small molecules—CYP7B1—prostate cancer	7.03e-05	0.00183	CbGpPWpGaD
Nitrofurantoin—Feeling abnormal—Capecitabine—prostate cancer	7e-05	0.000415	CcSEcCtD
Nitrofurantoin—Dizziness—Etoposide—prostate cancer	6.98e-05	0.000414	CcSEcCtD
Nitrofurantoin—Gastrointestinal pain—Capecitabine—prostate cancer	6.95e-05	0.000412	CcSEcCtD
Nitrofurantoin—Body temperature increased—Docetaxel—prostate cancer	6.94e-05	0.000412	CcSEcCtD
Nitrofurantoin—Abdominal pain—Docetaxel—prostate cancer	6.94e-05	0.000412	CcSEcCtD
Nitrofurantoin—Chills—Doxorubicin—prostate cancer	6.92e-05	0.00041	CcSEcCtD
Nitrofurantoin—Musculoskeletal discomfort—Prednisone—prostate cancer	6.9e-05	0.000409	CcSEcCtD
Nitrofurantoin—ABCG2—Transmembrane transport of small molecules—SLC26A4—prostate cancer	6.85e-05	0.00178	CbGpPWpGaD
Nitrofurantoin—ABCG2—Transmembrane transport of small molecules—SLC12A2—prostate cancer	6.85e-05	0.00178	CbGpPWpGaD
Nitrofurantoin—Alopecia—Doxorubicin—prostate cancer	6.81e-05	0.000404	CcSEcCtD
Nitrofurantoin—Paraesthesia—Prednisone—prostate cancer	6.8e-05	0.000403	CcSEcCtD
Nitrofurantoin—ABCG2—HIF-1-alpha transcription factor network—EP300—prostate cancer	6.76e-05	0.00176	CbGpPWpGaD
Nitrofurantoin—Ill-defined disorder—Epirubicin—prostate cancer	6.73e-05	0.000399	CcSEcCtD
Nitrofurantoin—Abdominal pain—Capecitabine—prostate cancer	6.72e-05	0.000399	CcSEcCtD
Nitrofurantoin—Body temperature increased—Capecitabine—prostate cancer	6.72e-05	0.000399	CcSEcCtD
Nitrofurantoin—Vomiting—Etoposide—prostate cancer	6.72e-05	0.000398	CcSEcCtD
Nitrofurantoin—Anaemia—Epirubicin—prostate cancer	6.71e-05	0.000398	CcSEcCtD
Nitrofurantoin—Dyspepsia—Prednisone—prostate cancer	6.66e-05	0.000395	CcSEcCtD
Nitrofurantoin—Rash—Etoposide—prostate cancer	6.66e-05	0.000395	CcSEcCtD
Nitrofurantoin—Headache—Etoposide—prostate cancer	6.62e-05	0.000393	CcSEcCtD
Nitrofurantoin—Flatulence—Doxorubicin—prostate cancer	6.61e-05	0.000392	CcSEcCtD
Nitrofurantoin—Decreased appetite—Prednisone—prostate cancer	6.58e-05	0.00039	CcSEcCtD
Nitrofurantoin—Malaise—Epirubicin—prostate cancer	6.54e-05	0.000388	CcSEcCtD
Nitrofurantoin—Vertigo—Epirubicin—prostate cancer	6.52e-05	0.000387	CcSEcCtD
Nitrofurantoin—Leukopenia—Epirubicin—prostate cancer	6.49e-05	0.000385	CcSEcCtD
Nitrofurantoin—Constipation—Prednisone—prostate cancer	6.47e-05	0.000384	CcSEcCtD
Nitrofurantoin—Hypersensitivity—Docetaxel—prostate cancer	6.47e-05	0.000384	CcSEcCtD
Nitrofurantoin—ABCG2—HIF-1-alpha transcription factor network—VEGFA—prostate cancer	6.4e-05	0.00166	CbGpPWpGaD
Nitrofurantoin—Cough—Epirubicin—prostate cancer	6.33e-05	0.000376	CcSEcCtD
Nitrofurantoin—Asthenia—Docetaxel—prostate cancer	6.3e-05	0.000374	CcSEcCtD
Nitrofurantoin—Nausea—Etoposide—prostate cancer	6.27e-05	0.000372	CcSEcCtD
Nitrofurantoin—ABCG2—Metabolism—HAO1—prostate cancer	6.27e-05	0.00163	CbGpPWpGaD
Nitrofurantoin—Hypersensitivity—Capecitabine—prostate cancer	6.26e-05	0.000371	CcSEcCtD
Nitrofurantoin—Feeling abnormal—Prednisone—prostate cancer	6.24e-05	0.00037	CcSEcCtD
Nitrofurantoin—Ill-defined disorder—Doxorubicin—prostate cancer	6.23e-05	0.000369	CcSEcCtD
Nitrofurantoin—Anaemia—Doxorubicin—prostate cancer	6.2e-05	0.000368	CcSEcCtD
Nitrofurantoin—Gastrointestinal pain—Prednisone—prostate cancer	6.19e-05	0.000367	CcSEcCtD
Nitrofurantoin—Chest pain—Epirubicin—prostate cancer	6.18e-05	0.000366	CcSEcCtD
Nitrofurantoin—Myalgia—Epirubicin—prostate cancer	6.18e-05	0.000366	CcSEcCtD
Nitrofurantoin—Discomfort—Epirubicin—prostate cancer	6.1e-05	0.000362	CcSEcCtD
Nitrofurantoin—Asthenia—Capecitabine—prostate cancer	6.1e-05	0.000362	CcSEcCtD
Nitrofurantoin—Malaise—Doxorubicin—prostate cancer	6.05e-05	0.000359	CcSEcCtD
Nitrofurantoin—Vertigo—Doxorubicin—prostate cancer	6.03e-05	0.000358	CcSEcCtD
Nitrofurantoin—Leukopenia—Doxorubicin—prostate cancer	6.01e-05	0.000356	CcSEcCtD
Nitrofurantoin—Diarrhoea—Docetaxel—prostate cancer	6.01e-05	0.000356	CcSEcCtD
Nitrofurantoin—Body temperature increased—Prednisone—prostate cancer	5.98e-05	0.000355	CcSEcCtD
Nitrofurantoin—Abdominal pain—Prednisone—prostate cancer	5.98e-05	0.000355	CcSEcCtD
Nitrofurantoin—Confusional state—Epirubicin—prostate cancer	5.97e-05	0.000354	CcSEcCtD
Nitrofurantoin—Anaphylactic shock—Epirubicin—prostate cancer	5.92e-05	0.000351	CcSEcCtD
Nitrofurantoin—Cough—Doxorubicin—prostate cancer	5.86e-05	0.000347	CcSEcCtD
Nitrofurantoin—Diarrhoea—Capecitabine—prostate cancer	5.81e-05	0.000345	CcSEcCtD
Nitrofurantoin—Dizziness—Docetaxel—prostate cancer	5.8e-05	0.000344	CcSEcCtD
Nitrofurantoin—Thrombocytopenia—Epirubicin—prostate cancer	5.8e-05	0.000344	CcSEcCtD
Nitrofurantoin—Chest pain—Doxorubicin—prostate cancer	5.71e-05	0.000339	CcSEcCtD
Nitrofurantoin—Myalgia—Doxorubicin—prostate cancer	5.71e-05	0.000339	CcSEcCtD
Nitrofurantoin—Discomfort—Doxorubicin—prostate cancer	5.65e-05	0.000335	CcSEcCtD
Nitrofurantoin—Anorexia—Epirubicin—prostate cancer	5.64e-05	0.000335	CcSEcCtD
Nitrofurantoin—Dizziness—Capecitabine—prostate cancer	5.62e-05	0.000333	CcSEcCtD
Nitrofurantoin—Vomiting—Docetaxel—prostate cancer	5.58e-05	0.000331	CcSEcCtD
Nitrofurantoin—Hypersensitivity—Prednisone—prostate cancer	5.58e-05	0.000331	CcSEcCtD
Nitrofurantoin—ABCG2—Transmembrane transport of small molecules—SLC22A3—prostate cancer	5.56e-05	0.00144	CbGpPWpGaD
Nitrofurantoin—Rash—Docetaxel—prostate cancer	5.53e-05	0.000328	CcSEcCtD
Nitrofurantoin—Confusional state—Doxorubicin—prostate cancer	5.52e-05	0.000328	CcSEcCtD
Nitrofurantoin—Headache—Docetaxel—prostate cancer	5.5e-05	0.000326	CcSEcCtD
Nitrofurantoin—Anaphylactic shock—Doxorubicin—prostate cancer	5.48e-05	0.000325	CcSEcCtD
Nitrofurantoin—Asthenia—Prednisone—prostate cancer	5.43e-05	0.000322	CcSEcCtD
Nitrofurantoin—Vomiting—Capecitabine—prostate cancer	5.4e-05	0.000321	CcSEcCtD
Nitrofurantoin—Musculoskeletal discomfort—Epirubicin—prostate cancer	5.39e-05	0.00032	CcSEcCtD
Nitrofurantoin—Thrombocytopenia—Doxorubicin—prostate cancer	5.36e-05	0.000318	CcSEcCtD
Nitrofurantoin—Rash—Capecitabine—prostate cancer	5.36e-05	0.000318	CcSEcCtD
Nitrofurantoin—Headache—Capecitabine—prostate cancer	5.32e-05	0.000316	CcSEcCtD
Nitrofurantoin—Paraesthesia—Epirubicin—prostate cancer	5.32e-05	0.000315	CcSEcCtD
Nitrofurantoin—Dyspnoea—Epirubicin—prostate cancer	5.28e-05	0.000313	CcSEcCtD
Nitrofurantoin—Somnolence—Epirubicin—prostate cancer	5.26e-05	0.000312	CcSEcCtD
Nitrofurantoin—Anorexia—Doxorubicin—prostate cancer	5.22e-05	0.00031	CcSEcCtD
Nitrofurantoin—Nausea—Docetaxel—prostate cancer	5.21e-05	0.000309	CcSEcCtD
Nitrofurantoin—Dyspepsia—Epirubicin—prostate cancer	5.21e-05	0.000309	CcSEcCtD
Nitrofurantoin—Diarrhoea—Prednisone—prostate cancer	5.18e-05	0.000307	CcSEcCtD
Nitrofurantoin—Decreased appetite—Epirubicin—prostate cancer	5.15e-05	0.000305	CcSEcCtD
Nitrofurantoin—ABCG2—Transmembrane transport of small molecules—ABCG5—prostate cancer	5.13e-05	0.00133	CbGpPWpGaD
Nitrofurantoin—Gastrointestinal disorder—Epirubicin—prostate cancer	5.11e-05	0.000303	CcSEcCtD
Nitrofurantoin—ABCG2—Metabolism—TST—prostate cancer	5.11e-05	0.00133	CbGpPWpGaD
Nitrofurantoin—ABCG2—Metabolism—PSAT1—prostate cancer	5.11e-05	0.00133	CbGpPWpGaD
Nitrofurantoin—ABCG2—Metabolism—CBR1—prostate cancer	5.11e-05	0.00133	CbGpPWpGaD
Nitrofurantoin—ABCG2—Metabolism—GRHL1—prostate cancer	5.11e-05	0.00133	CbGpPWpGaD
Nitrofurantoin—ABCG2—Metabolism—CSAD—prostate cancer	5.11e-05	0.00133	CbGpPWpGaD
Nitrofurantoin—ABCG2—Metabolism—ADI1—prostate cancer	5.11e-05	0.00133	CbGpPWpGaD
Nitrofurantoin—Constipation—Epirubicin—prostate cancer	5.06e-05	0.0003	CcSEcCtD
Nitrofurantoin—Nausea—Capecitabine—prostate cancer	5.05e-05	0.000299	CcSEcCtD
Nitrofurantoin—Dizziness—Prednisone—prostate cancer	5.01e-05	0.000297	CcSEcCtD
Nitrofurantoin—Musculoskeletal discomfort—Doxorubicin—prostate cancer	4.99e-05	0.000296	CcSEcCtD
Nitrofurantoin—Paraesthesia—Doxorubicin—prostate cancer	4.92e-05	0.000292	CcSEcCtD
Nitrofurantoin—Dyspnoea—Doxorubicin—prostate cancer	4.88e-05	0.00029	CcSEcCtD
Nitrofurantoin—Feeling abnormal—Epirubicin—prostate cancer	4.88e-05	0.000289	CcSEcCtD
Nitrofurantoin—Somnolence—Doxorubicin—prostate cancer	4.87e-05	0.000289	CcSEcCtD
Nitrofurantoin—Gastrointestinal pain—Epirubicin—prostate cancer	4.84e-05	0.000287	CcSEcCtD
Nitrofurantoin—Dyspepsia—Doxorubicin—prostate cancer	4.82e-05	0.000286	CcSEcCtD
Nitrofurantoin—Vomiting—Prednisone—prostate cancer	4.81e-05	0.000286	CcSEcCtD
Nitrofurantoin—Rash—Prednisone—prostate cancer	4.77e-05	0.000283	CcSEcCtD
Nitrofurantoin—Decreased appetite—Doxorubicin—prostate cancer	4.76e-05	0.000283	CcSEcCtD
Nitrofurantoin—ABCG2—Metabolism—UGT2B17—prostate cancer	4.75e-05	0.00123	CbGpPWpGaD
Nitrofurantoin—ABCG2—Metabolism—CKMT2—prostate cancer	4.75e-05	0.00123	CbGpPWpGaD
Nitrofurantoin—ABCG2—Metabolism—GRHPR—prostate cancer	4.75e-05	0.00123	CbGpPWpGaD
Nitrofurantoin—ABCG2—Metabolism—UGT2B15—prostate cancer	4.75e-05	0.00123	CbGpPWpGaD
Nitrofurantoin—Headache—Prednisone—prostate cancer	4.74e-05	0.000281	CcSEcCtD
Nitrofurantoin—Gastrointestinal disorder—Doxorubicin—prostate cancer	4.73e-05	0.000281	CcSEcCtD
Nitrofurantoin—Constipation—Doxorubicin—prostate cancer	4.68e-05	0.000278	CcSEcCtD
Nitrofurantoin—Body temperature increased—Epirubicin—prostate cancer	4.68e-05	0.000278	CcSEcCtD
Nitrofurantoin—Abdominal pain—Epirubicin—prostate cancer	4.68e-05	0.000278	CcSEcCtD
Nitrofurantoin—ABCG2—Transmembrane transport of small molecules—SLC22A1—prostate cancer	4.53e-05	0.00118	CbGpPWpGaD
Nitrofurantoin—Feeling abnormal—Doxorubicin—prostate cancer	4.51e-05	0.000268	CcSEcCtD
Nitrofurantoin—Nausea—Prednisone—prostate cancer	4.5e-05	0.000267	CcSEcCtD
Nitrofurantoin—Gastrointestinal pain—Doxorubicin—prostate cancer	4.48e-05	0.000266	CcSEcCtD
Nitrofurantoin—ABCG2—Metabolism—MBTPS1—prostate cancer	4.47e-05	0.00116	CbGpPWpGaD
Nitrofurantoin—ABCG2—Metabolism—PGAM2—prostate cancer	4.47e-05	0.00116	CbGpPWpGaD
Nitrofurantoin—ABCG2—Metabolism—AOX1—prostate cancer	4.47e-05	0.00116	CbGpPWpGaD
Nitrofurantoin—ABCG2—Metabolism—RFK—prostate cancer	4.47e-05	0.00116	CbGpPWpGaD
Nitrofurantoin—ABCG2—Metabolism—GSTM3—prostate cancer	4.47e-05	0.00116	CbGpPWpGaD
Nitrofurantoin—ABCG2—Metabolism—SULT2B1—prostate cancer	4.47e-05	0.00116	CbGpPWpGaD
Nitrofurantoin—ABCG2—Metabolism—NAGLU—prostate cancer	4.47e-05	0.00116	CbGpPWpGaD
Nitrofurantoin—Hypersensitivity—Epirubicin—prostate cancer	4.36e-05	0.000259	CcSEcCtD
Nitrofurantoin—Body temperature increased—Doxorubicin—prostate cancer	4.33e-05	0.000257	CcSEcCtD
Nitrofurantoin—Abdominal pain—Doxorubicin—prostate cancer	4.33e-05	0.000257	CcSEcCtD
Nitrofurantoin—ABCG2—Transmembrane transport of small molecules—GNG5—prostate cancer	4.31e-05	0.00112	CbGpPWpGaD
Nitrofurantoin—Asthenia—Epirubicin—prostate cancer	4.25e-05	0.000252	CcSEcCtD
Nitrofurantoin—ABCG2—Metabolism—NAT1—prostate cancer	4.24e-05	0.0011	CbGpPWpGaD
Nitrofurantoin—ABCG2—Metabolism—AMACR—prostate cancer	4.24e-05	0.0011	CbGpPWpGaD
Nitrofurantoin—ABCG2—Metabolism—SRD5A2—prostate cancer	4.24e-05	0.0011	CbGpPWpGaD
Nitrofurantoin—ABCG2—Metabolism—CYP3A43—prostate cancer	4.24e-05	0.0011	CbGpPWpGaD
Nitrofurantoin—ABCG2—Metabolism—DEGS1—prostate cancer	4.24e-05	0.0011	CbGpPWpGaD
Nitrofurantoin—ABCG2—HIF-1-alpha transcription factor network—AKT1—prostate cancer	4.09e-05	0.00106	CbGpPWpGaD
Nitrofurantoin—Diarrhoea—Epirubicin—prostate cancer	4.05e-05	0.00024	CcSEcCtD
Nitrofurantoin—ABCG2—Metabolism—HSD17B1—prostate cancer	4.04e-05	0.00105	CbGpPWpGaD
Nitrofurantoin—Hypersensitivity—Doxorubicin—prostate cancer	4.04e-05	0.000239	CcSEcCtD
Nitrofurantoin—Asthenia—Doxorubicin—prostate cancer	3.93e-05	0.000233	CcSEcCtD
Nitrofurantoin—Dizziness—Epirubicin—prostate cancer	3.92e-05	0.000232	CcSEcCtD
Nitrofurantoin—Vomiting—Epirubicin—prostate cancer	3.76e-05	0.000223	CcSEcCtD
Nitrofurantoin—Diarrhoea—Doxorubicin—prostate cancer	3.75e-05	0.000222	CcSEcCtD
Nitrofurantoin—Rash—Epirubicin—prostate cancer	3.73e-05	0.000221	CcSEcCtD
Nitrofurantoin—Headache—Epirubicin—prostate cancer	3.71e-05	0.00022	CcSEcCtD
Nitrofurantoin—ABCG2—Transmembrane transport of small molecules—PRKACB—prostate cancer	3.67e-05	0.000955	CbGpPWpGaD
Nitrofurantoin—Dizziness—Doxorubicin—prostate cancer	3.62e-05	0.000215	CcSEcCtD
Nitrofurantoin—ABCG2—Metabolism—HPGD—prostate cancer	3.6e-05	0.000936	CbGpPWpGaD
Nitrofurantoin—ABCG2—Metabolism—B4GALT4—prostate cancer	3.6e-05	0.000936	CbGpPWpGaD
Nitrofurantoin—Nausea—Epirubicin—prostate cancer	3.52e-05	0.000209	CcSEcCtD
Nitrofurantoin—Vomiting—Doxorubicin—prostate cancer	3.48e-05	0.000207	CcSEcCtD
Nitrofurantoin—ABCG2—Transmembrane transport of small molecules—NCOA2—prostate cancer	3.47e-05	0.000901	CbGpPWpGaD
Nitrofurantoin—Rash—Doxorubicin—prostate cancer	3.45e-05	0.000205	CcSEcCtD
Nitrofurantoin—Headache—Doxorubicin—prostate cancer	3.43e-05	0.000204	CcSEcCtD
Nitrofurantoin—ABCG2—Metabolism—TNFRSF21—prostate cancer	3.39e-05	0.00088	CbGpPWpGaD
Nitrofurantoin—ABCG2—Transmembrane transport of small molecules—SLC5A5—prostate cancer	3.31e-05	0.000859	CbGpPWpGaD
Nitrofurantoin—ABCG2—Metabolism—CYP7B1—prostate cancer	3.29e-05	0.000856	CbGpPWpGaD
Nitrofurantoin—ABCG2—Metabolism—MTAP—prostate cancer	3.29e-05	0.000856	CbGpPWpGaD
Nitrofurantoin—Nausea—Doxorubicin—prostate cancer	3.25e-05	0.000193	CcSEcCtD
Nitrofurantoin—ABCG2—Metabolism—SULT1E1—prostate cancer	3.21e-05	0.000834	CbGpPWpGaD
Nitrofurantoin—ABCG2—Metabolism—SRD5A1—prostate cancer	3.21e-05	0.000834	CbGpPWpGaD
Nitrofurantoin—ABCG2—Metabolism—HSD17B3—prostate cancer	3.06e-05	0.000796	CbGpPWpGaD
Nitrofurantoin—ABCG2—Metabolism—ACSL4—prostate cancer	3.06e-05	0.000796	CbGpPWpGaD
Nitrofurantoin—ABCG2—Metabolism—UMPS—prostate cancer	2.94e-05	0.000763	CbGpPWpGaD
Nitrofurantoin—ABCG2—Metabolism—ARG2—prostate cancer	2.94e-05	0.000763	CbGpPWpGaD
Nitrofurantoin—ABCG2—Metabolism—PHGDH—prostate cancer	2.94e-05	0.000763	CbGpPWpGaD
Nitrofurantoin—ABCG2—Transmembrane transport of small molecules—NCOA1—prostate cancer	2.92e-05	0.000759	CbGpPWpGaD
Nitrofurantoin—ABCG2—Metabolism—LDHB—prostate cancer	2.88e-05	0.000748	CbGpPWpGaD
Nitrofurantoin—ABCG2—Metabolism—CYP3A5—prostate cancer	2.83e-05	0.000734	CbGpPWpGaD
Nitrofurantoin—ABCG2—Transmembrane transport of small molecules—RXRA—prostate cancer	2.78e-05	0.000722	CbGpPWpGaD
Nitrofurantoin—ABCG2—Metabolism—TCN2—prostate cancer	2.73e-05	0.000709	CbGpPWpGaD
Nitrofurantoin—ABCG2—Metabolism—PDHA1—prostate cancer	2.73e-05	0.000709	CbGpPWpGaD
Nitrofurantoin—ABCG2—Metabolism—GSTA3—prostate cancer	2.73e-05	0.000709	CbGpPWpGaD
Nitrofurantoin—ABCG2—Metabolism—UCP3—prostate cancer	2.73e-05	0.000709	CbGpPWpGaD
Nitrofurantoin—ABCG2—Metabolism—SLC22A3—prostate cancer	2.6e-05	0.000677	CbGpPWpGaD
Nitrofurantoin—ABCG2—Metabolism—HSD3B1—prostate cancer	2.6e-05	0.000677	CbGpPWpGaD
Nitrofurantoin—ABCG2—Metabolism—TBXAS1—prostate cancer	2.5e-05	0.000649	CbGpPWpGaD
Nitrofurantoin—ABCG2—Metabolism—GSTA4—prostate cancer	2.5e-05	0.000649	CbGpPWpGaD
Nitrofurantoin—ABCG2—Metabolism—GSTA2—prostate cancer	2.43e-05	0.000632	CbGpPWpGaD
Nitrofurantoin—ABCG2—Metabolism—ABCG5—prostate cancer	2.4e-05	0.000624	CbGpPWpGaD
Nitrofurantoin—ABCG2—Metabolism—SULT1A1—prostate cancer	2.4e-05	0.000624	CbGpPWpGaD
Nitrofurantoin—ABCG2—Metabolism—GSTA1—prostate cancer	2.35e-05	0.00061	CbGpPWpGaD
Nitrofurantoin—ABCG2—Metabolism—NAT2—prostate cancer	2.32e-05	0.000603	CbGpPWpGaD
Nitrofurantoin—ABCG2—Metabolism—HSD3B2—prostate cancer	2.32e-05	0.000603	CbGpPWpGaD
Nitrofurantoin—ABCG2—Metabolism—GSTO1—prostate cancer	2.32e-05	0.000603	CbGpPWpGaD
Nitrofurantoin—ABCG2—Metabolism—PLCB2—prostate cancer	2.22e-05	0.000578	CbGpPWpGaD
Nitrofurantoin—ABCG2—Metabolism—LRP2—prostate cancer	2.22e-05	0.000578	CbGpPWpGaD
Nitrofurantoin—ABCG2—Metabolism—CYP2C18—prostate cancer	2.22e-05	0.000578	CbGpPWpGaD
Nitrofurantoin—ABCG2—Metabolism—P4HB—prostate cancer	2.18e-05	0.000567	CbGpPWpGaD
Nitrofurantoin—ABCG2—Metabolism—SLC22A1—prostate cancer	2.12e-05	0.000552	CbGpPWpGaD
Nitrofurantoin—ABCG2—Transmembrane transport of small molecules—PPARA—prostate cancer	2.12e-05	0.000551	CbGpPWpGaD
Nitrofurantoin—ABCG2—Metabolism—SULT2A1—prostate cancer	2.07e-05	0.000538	CbGpPWpGaD
Nitrofurantoin—ABCG2—Metabolism—MED12—prostate cancer	2.03e-05	0.000529	CbGpPWpGaD
Nitrofurantoin—ABCG2—Metabolism—GNG5—prostate cancer	2.02e-05	0.000525	CbGpPWpGaD
Nitrofurantoin—ABCG2—Metabolism—NCOA3—prostate cancer	1.94e-05	0.000505	CbGpPWpGaD
Nitrofurantoin—ABCG2—Metabolism—HPGDS—prostate cancer	1.86e-05	0.000482	CbGpPWpGaD
Nitrofurantoin—ABCG2—Metabolism—CYP2C19—prostate cancer	1.84e-05	0.000479	CbGpPWpGaD
Nitrofurantoin—ABCG2—Metabolism—GSTT1—prostate cancer	1.8e-05	0.000468	CbGpPWpGaD
Nitrofurantoin—ABCG2—Metabolism—ACHE—prostate cancer	1.8e-05	0.000468	CbGpPWpGaD
Nitrofurantoin—ABCG2—Metabolism—CYP2A6—prostate cancer	1.78e-05	0.000462	CbGpPWpGaD
Nitrofurantoin—ABCG2—Metabolism—AKR1C3—prostate cancer	1.73e-05	0.00045	CbGpPWpGaD
Nitrofurantoin—ABCG2—Metabolism—PRKACB—prostate cancer	1.72e-05	0.000447	CbGpPWpGaD
Nitrofurantoin—ABCG2—Metabolism—CYP17A1—prostate cancer	1.7e-05	0.000443	CbGpPWpGaD
Nitrofurantoin—ABCG2—Transmembrane transport of small molecules—CREBBP—prostate cancer	1.68e-05	0.000438	CbGpPWpGaD
Nitrofurantoin—ABCG2—Metabolism—NCOA2—prostate cancer	1.62e-05	0.000422	CbGpPWpGaD
Nitrofurantoin—ABCG2—Metabolism—SLC5A5—prostate cancer	1.55e-05	0.000402	CbGpPWpGaD
Nitrofurantoin—ABCG2—Metabolism—CYP2E1—prostate cancer	1.51e-05	0.000393	CbGpPWpGaD
Nitrofurantoin—ABCG2—Metabolism—NQO1—prostate cancer	1.5e-05	0.000389	CbGpPWpGaD
Nitrofurantoin—ABCG2—Metabolism—TH—prostate cancer	1.47e-05	0.000383	CbGpPWpGaD
Nitrofurantoin—ABCG2—Metabolism—CYP3A4—prostate cancer	1.46e-05	0.000379	CbGpPWpGaD
Nitrofurantoin—ABCG2—Metabolism—CYP1B1—prostate cancer	1.43e-05	0.000373	CbGpPWpGaD
Nitrofurantoin—ABCG2—Metabolism—GGT1—prostate cancer	1.39e-05	0.000361	CbGpPWpGaD
Nitrofurantoin—ABCG2—Metabolism—NCOA1—prostate cancer	1.37e-05	0.000355	CbGpPWpGaD
Nitrofurantoin—ABCG2—Metabolism—CYP19A1—prostate cancer	1.35e-05	0.00035	CbGpPWpGaD
Nitrofurantoin—ABCG2—Metabolism—RXRA—prostate cancer	1.3e-05	0.000338	CbGpPWpGaD
Nitrofurantoin—ABCG2—Metabolism—COMT—prostate cancer	1.25e-05	0.000326	CbGpPWpGaD
Nitrofurantoin—ABCG2—Metabolism—GSTP1—prostate cancer	1.25e-05	0.000324	CbGpPWpGaD
Nitrofurantoin—ABCG2—Metabolism—ITPR1—prostate cancer	1.23e-05	0.000319	CbGpPWpGaD
Nitrofurantoin—ABCG2—Metabolism—TYMS—prostate cancer	1.16e-05	0.000301	CbGpPWpGaD
Nitrofurantoin—ABCG2—Metabolism—GSTM1—prostate cancer	1.15e-05	0.000298	CbGpPWpGaD
Nitrofurantoin—ABCG2—Metabolism—LPL—prostate cancer	1.12e-05	0.000292	CbGpPWpGaD
Nitrofurantoin—ABCG2—Metabolism—CYP1A1—prostate cancer	1.09e-05	0.000282	CbGpPWpGaD
Nitrofurantoin—ABCG2—Metabolism—ERCC2—prostate cancer	1.08e-05	0.00028	CbGpPWpGaD
Nitrofurantoin—ABCG2—Metabolism—MTHFR—prostate cancer	1.01e-05	0.000263	CbGpPWpGaD
Nitrofurantoin—ABCG2—Metabolism—PPARA—prostate cancer	9.94e-06	0.000258	CbGpPWpGaD
Nitrofurantoin—ABCG2—Metabolism—CAV1—prostate cancer	9.34e-06	0.000243	CbGpPWpGaD
Nitrofurantoin—ABCG2—Metabolism—PIK3CG—prostate cancer	8.51e-06	0.000221	CbGpPWpGaD
Nitrofurantoin—ABCG2—Metabolism—INS—prostate cancer	8.06e-06	0.000209	CbGpPWpGaD
Nitrofurantoin—ABCG2—Metabolism—CREBBP—prostate cancer	7.89e-06	0.000205	CbGpPWpGaD
Nitrofurantoin—ABCG2—Metabolism—PIK3CD—prostate cancer	7.48e-06	0.000194	CbGpPWpGaD
Nitrofurantoin—ABCG2—Metabolism—NOS3—prostate cancer	7.06e-06	0.000184	CbGpPWpGaD
Nitrofurantoin—ABCG2—Metabolism—PIK3CB—prostate cancer	6.52e-06	0.000169	CbGpPWpGaD
Nitrofurantoin—ABCG2—Metabolism—PTGS2—prostate cancer	6.46e-06	0.000168	CbGpPWpGaD
Nitrofurantoin—ABCG2—Metabolism—PTEN—prostate cancer	5.63e-06	0.000146	CbGpPWpGaD
Nitrofurantoin—ABCG2—Metabolism—EP300—prostate cancer	5.37e-06	0.00014	CbGpPWpGaD
Nitrofurantoin—ABCG2—Metabolism—PIK3CA—prostate cancer	3.98e-06	0.000103	CbGpPWpGaD
Nitrofurantoin—ABCG2—Metabolism—AKT1—prostate cancer	3.25e-06	8.44e-05	CbGpPWpGaD
